Novus Therapeutics found using ticker (NVUS) now have 3 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 43 and 27 and has a mean target at 35. Now with the previous closing price of 15.4 this indicates there is a potential upside of 127.3%. There is a 50 day moving average of 15.71 and the 200 moving average now moves to 15.63. The company has a market cap of $21m. Visit the company website at: 0
0
You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.
